Taysha Gene Therapies (TSHA)'s 30-day implied volatility (IV30) was 62.5% at the close on October 22, 2026, down from 70.5% the day before, against a 52-week range of 46.5% to 122.3%. Its 20-day historical volatility was 70.3%.
Data as of October 22, 2026.